Adult DRV/r (400/50mg) FAQs for Communities and PLHIV
CHAI developed these frequently asked questions (FAQs) to lay out information for communities and PLHIV on the subject of DRV/r (400/50...
A framework to support new product introduction in national health systems
Resource Library
- Mar 22
Customizable Adult DRV/r (400/50mg) Healthcare Worker Training Slides
CHAI has developed a generic training curriculum that is intended to be adapted for local contexts and their respective training plans.
67
- Mar 17
Adult DRV/r (400/50mg) Clinical Action Memo
Darunavir (DRV) is a best-in-class protease inhibitor (PI) used in combination with other antiretroviral (ARV) drugs for the...
108
- Mar 17
Customizable Adult DRV/r (400/50mg) Prescribing Algorithm
CHAI is pleased to share a customizable guide to assist healthcare workers with prescribing and dispensing second-line (2L) DRV/r...
63
- Mar 16
CHAI DRV/r 2L Product Profile
A presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
73
- Mar 16
DRV/r (400/50mg) FAQs
CHAI developed these frequently asked questions (FAQs) to lay out information for national HIV programs considering the adoption and...
42
- Oct 7, 2021
CHAI Simple Tool Adults & Pediatrics
The CHAI Simple Tool is a morbidity-based forecasting tool that quantifies ARV needs over a three year period for an HIV/AIDS treatment...
135
- Jan 1, 2021
CHAI Rapid Consumption Monitoring Tool
As national programs continue to rollout new generic ARVs, there is a need for routine, careful monitoring of product uptake to ensure...
26
- Jan 1, 2021
CHAI National Stock Status Dashboard
Keeping an adequate stock of ARVs on hand is important for multiple reasons. Too much stock, and programs run the risk of products...
24